Gülsüm Kaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Gülsüm Kaya
Affiliation Yalova University
Country Turkey
Scopus ID 56589615100
Documents 17
Citations 731
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
Google Scholar ID d9woUXQAAAAJ

Gülsüm Kaya
Yalova University, Turkey

Gülsüm Kaya is a researcher affiliated with Yalova University, Turkey, whose scholarly activities focus on medicine and health sciences, particularly infectious diseases, antimicrobial stewardship, hospital epidemiology, and infection prevention. Her publication record demonstrates collaborative participation in internationally recognized multicenter investigations addressing healthcare-associated infections, surveillance systems, and evidence-based clinical practice. Through contributions to high-impact journals and multinational research networks, her work supports improved patient safety and infection control strategies in healthcare institutions while advancing scientific understanding of nosocomial infections.[1]

Abstract

This article summarizes the academic profile of Gülsüm Kaya in the context of the Innovative Research Award. Her scholarly contributions encompass infection prevention, antimicrobial utilization, hospital surveillance, and clinical outcomes associated with healthcare-associated infections. Participation in influential international collaborations, including the International Nosocomial Infection Control Consortium (INICC), has contributed to globally cited publications supporting evidence-based infection control practices.[2]

Keywords

Healthcare-associated infections, Infection control, Hospital epidemiology, Antimicrobial stewardship, Nosocomial infections, Clinical microbiology, Patient safety, Medicine and Health Sciences.

Introduction

Modern healthcare systems increasingly rely on multidisciplinary research to reduce infection-related morbidity and improve treatment quality. Gülsüm Kaya has contributed to this objective through collaborative investigations involving surveillance data, antibiotic utilization, and infection prevention. These studies support healthcare policy development and promote standardized approaches to patient safety in hospitals across multiple countries.[3]

Research Profile

According to the supplied scholarly metrics, the researcher has published 17 Scopus-indexed documents, received 731 citations, and achieved an h-index of 8. Her work primarily addresses infectious diseases, antimicrobial therapy, hospital-acquired infections, and epidemiological surveillance. Collaboration with international researchers demonstrates active participation in globally recognized scientific initiatives that generate evidence for healthcare quality improvement.[1]

Research Contributions

Major research contributions include participation in multinational INICC surveillance reports covering dozens of countries, investigations of surgical site infection rates across Turkey, multicenter assessments of antibiotic consumption, and clinical evaluations of antimicrobial therapies for Gram-negative nosocomial infections. These studies provide valuable epidemiological evidence supporting infection control guidelines and healthcare quality assessment.[2]

Publications

  • International Nosocomial Infection Control Consortium report covering 50 countries (2016).
  • INICC device-associated infection report involving 43 countries (2014).
  • Surgical site infection rates across sixteen Turkish cities.
  • Multicenter prevalence study of antibiotic consumption in Turkish hospitals.
  • Clinical outcomes of cefoperazone-sulbactam versus piperacillin-tazobactam therapy.

Research Impact

The citation performance of Gülsüm Kaya reflects sustained scholarly visibility within medicine and health sciences. Highly cited collaborative publications have informed international surveillance practices and strengthened evidence supporting infection prevention initiatives. The combination of clinical relevance, multinational collaboration, and measurable citation impact illustrates meaningful academic influence within the field.[4]

Award Suitability

The research portfolio demonstrates qualities commonly associated with international academic recognition, including collaborative scholarship, publication in peer-reviewed journals, measurable citation impact, and contributions to evidence-based healthcare practice. These characteristics align with the objectives of the Global Innovation Technologist Awards in recognizing research that advances innovation and scientific excellence within medicine and health sciences.[5]

Conclusion

Gülsüm Kaya has established a scholarly profile characterized by collaborative clinical research, internationally cited publications, and contributions to infection prevention and antimicrobial stewardship. Her work supports healthcare quality improvement through evidence generation and multidisciplinary cooperation, making her academic achievements noteworthy within the broader field of medicine and health sciences.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Gülsüm Kaya, Author ID 56589615100.
    https://www.scopus.com/pages/authors/56589615100
  2. Rosenthal VD, et al. (2016). International Nosocomial Infection Control Consortium report. American Journal of Infection Control.
  3. Rosenthal VD, et al. (2014). INICC report: Device-associated module.
    https://doi.org/10.1016/j.ajic.2014.05.029
  4. Leblebicioglu H, et al. (2015). Surgical site infection rates in Turkey.
    https://doi.org/10.1016/j.ajic.2014.08.017
  5. Guclu E, Kaya G, et al. (2020). The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality.
    https://doi.org/10.1080/1120009X.2019.1696735
  6. Guclu E, et al. (2017). Antibiotic consumption in Turkish hospitals.
    https://doi.org/10.1080/1120009X.2016.1235738

Aleksandra Kułakowska | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Aleksandra Kułakowska
University of Opole

Aleksandra Kułakowska
Affiliation University of Opole
Country Poland
Documents 9
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-5466-7167

Aleksandra Kułakowska is a researcher affiliated with the University of Opole whose scholarly work contributes to contemporary discussions in medicine, public health, patient care, and clinical practice. Her publications explore diverse healthcare topics including nephrology, cardiology, dermatology, women’s health, infection prevention, and quality-of-life assessment. Through peer-reviewed academic articles, she has participated in the dissemination of evidence-based medical knowledge and interdisciplinary healthcare perspectives.[1]

Abstract

This article presents an overview of the academic profile and scholarly contributions of Aleksandra Kułakowska. Her published work addresses clinically relevant healthcare challenges, emphasizing patient well-being, disease management, preventive medicine, and evidence-based healthcare practices. The breadth of topics represented within her publication portfolio demonstrates engagement with multidisciplinary medical research and healthcare education.[2]

Keywords

Medicine, Health Sciences, Clinical Research, Patient Care, Public Health, Dialysis, Medical Education, Healthcare Quality.

Introduction

Healthcare research plays an important role in improving patient outcomes and informing clinical decision-making. Aleksandra Kułakowska’s academic contributions align with this objective by addressing issues related to chronic disease management, healthcare quality, and patient-centered care. Her work contributes to broader efforts aimed at enhancing understanding of medical conditions and treatment outcomes.[3]

Research Profile

The research interests of Aleksandra Kułakowska encompass several areas of medicine and health sciences. Her publications address dialysis and quality of life, mental health implications of chronic treatment, surgical site infection prevention, women’s health, cardiovascular disorders such as Brugada syndrome, and rare dermatological conditions including Schnitzler syndrome. These studies demonstrate interdisciplinary engagement with contemporary healthcare topics.[4]

Research Contributions

  • Evaluation of quality-of-life outcomes among dialysis patients.
  • Assessment of mental health considerations associated with chronic renal therapy.
  • Review of updated guidelines concerning surgical site infections.
  • Analysis of healthy lifestyle interventions for patients experiencing PMS symptoms.
  • Compilation of clinically relevant information regarding Brugada syndrome.

Publications

  • Schnitzler syndrome – a rare cause of chronic urticaria. Case report (2025).
  • What impact does dialysis have on the patient’s life and mental health? (2023).
  • Dialysotherapy effect on the quality of life for renal patients (2023).
  • Surgical site infections – an updated review of guidelines (2023).
  • Holistic care, physical activity and healthy lifestyle in PMS patients (2023).

Research Impact

The published studies contribute to healthcare education and clinical awareness by synthesizing current evidence and discussing practical implications for patient care. Topics such as chronic disease management, infection prevention, and rare disease recognition are relevant to clinicians, healthcare educators, and medical researchers. The diversity of subjects represented in her work reflects a commitment to supporting informed healthcare practice.[5]

Award Suitability

Aleksandra Kułakowska’s scholarly activities align with the objectives of the Global Innovation Technologist Awards by demonstrating engagement with healthcare innovation, medical knowledge dissemination, and interdisciplinary research. Her publication record highlights contributions to clinically relevant topics that support evidence-based practice and ongoing scientific dialogue within medicine and health sciences.[6]

Conclusion

Aleksandra Kułakowska has contributed to a range of healthcare-related subjects through peer-reviewed publications addressing patient outcomes, clinical management, and public health concerns. Her academic portfolio reflects sustained engagement with contemporary medical issues and supports the advancement of healthcare knowledge through scholarly communication.

References

  1. ORCID. (n.d.). Aleksandra Kułakowska ORCID record.
    https://orcid.org/0000-0001-5466-7167
  2. Oxford Medical Case Reports. (2025). Schnitzler syndrome – a rare cause of chronic urticaria. Case report.
    DOI: https://doi.org/10.1093/omcr/omaf118
  3. Journal of Education, Health and Sport. (2023). What impact does dialysis have on the patient’s life and mental health?
    DOI: https://doi.org/10.12775/JEHS.2023.39.01.001
  4. Journal of Education, Health and Sport. (2023). Dialysotherapy effect on the quality of life for renal patients.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.006
  5. Journal of Education, Health and Sport. (2023). Surgical site infections – an updated review of guidelines in the light of new scientific data.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.002
  6. Journal of Education, Health and Sport. (2023). Concise compilation of the most clinically relevant current knowledge on Brugada Syndrome.
    DOI: https://doi.org/10.12775/JEHS.2023.25.01.001

Jiawen Wang | Medicine | Best Researcher Award

Published on by Innovation Technologist

Dr. Jiawen Wang | Medicine | Best Researcher Award

Surgeon at Longhua Hospital Shanghai University of Traditional Chinese Medicine | China

Jiawen Wang is a distinguished surgeon and deputy chief physician at a leading hospital specializing in Traditional Chinese Medicine, with a focused expertise in colorectal surgery and integrative medicine. She has made significant contributions to the clinical management of anorectal disorders and inflammatory bowel disease, combining traditional Chinese medicine approaches with minimally invasive surgical and endoscopic interventional techniques. As a principal investigator and key researcher in multiple competitive research projects, she has led studies that bridge traditional practices with modern medical science, investigating clinical outcomes and underlying biological mechanisms. Her scholarly output includes numerous peer-reviewed publications, contributions to books, and active participation as a reviewer for several academic journals. Her work has garnered recognition through multiple awards and patents, reflecting innovation and clinical impact. Collaborating with prominent institutions both nationally and internationally, she has advanced the application of integrative medicine in gastroenterology and pelvic floor medicine. She is also actively involved in professional societies, holding leadership and committee roles that influence clinical standards, research priorities, and training programs in colorectal and integrative medicine. Her contributions are characterized by the integration of traditional methodologies with evidence-based research, promoting high standards in both clinical practice and academic scholarship. She has achieved a total of 116 citations, with 112 citations since 2020, an h-index of 4 overall and since 2020, and an i10-index of 2 both total and since 2020, reflecting the recognition and influence of her work within the scientific and medical community. Her research and clinical practice demonstrate a unique capacity to combine innovation, rigorous scientific validation, and practical applicability, establishing her as a leading figure in the advancement of integrative approaches to colorectal and gastrointestinal medicine.

Profile: Orcid | Google Scholar

Featured Publications

1. Wang, J. W., Pan, Y. B., Cao, Y. Q., Wang, C., Jiang, W. D., Zhai, W. F., & Lu, J. G. (2020). Loganin alleviates LPS‐activated intestinal epithelial inflammation by regulating TLR4/NF‐κB and JAK/STAT3 signaling pathways. The Kaohsiung Journal of Medical Sciences, 36(4), 257–264.

2. Wang, J., Pan, Y., Cao, Y., Zhou, W., & Lu, J. (2019). Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways. Iranian Journal of Basic Medical Sciences, 22(1), 31.

3. Jiang, X., Chen, X., Dong, R., Wang, J., Pan, Y., & Cao, Y. (2023). Establishment of a mouse model of inflammatory bowel disease using dextran sulfate sodium. Advances in Clinical and Experimental Medicine, 32(5), 563–573.

4. Luo, Q., Wang, J., Ge, W., Li, Z., Mao, Y., Wang, C., & Zhang, L. (2024). Exploration of the potential causative genes for inflammatory bowel disease: Transcriptome-wide association analysis, Mendelian randomization analysis and Bayesian colocalisation. Heliyon, 10(7), [Article 7].

5. Liao, W., Luo, Q., Zhang, L., Wang, H., Ge, W., Wang, J., & Zuo, Z. (2024). Genetic overlap between inflammatory bowel disease and iridocyclitis: Insights from a genome-wide association study in a European population. BMC Genomic Data, 25(1), 92.